Records containing: Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-23Ototoxicity Monitoring and Remote Audiometry
-
CLINICAL_TRIALS study record update · 2026-03-11Pembrolizumab for Orbital and Periocular Cutaneous Squamous Cell Carcinoma (cSCC)
-
CLINICAL_TRIALS study record update · 2026-02-25Phase II Study of REGN2810 Prior to Surgery in Patients With Stage II-IV Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck
-
CLINICAL_TRIALS study record update · 2024-12-13Phase I Trial of BAY 1895344 ATR Inhibitor Combined With Stereotactic Body Radiation Therapy and Pembrolizumab for Recurrent Head and Neck Squamous Cell Carcinoma